Nowak P, Mueller T C, Jørgensen K. "Method for the Synthesis of Dalbavancin Impurity 21" [P]. European Patent, EP 3075364 A1, 2018-04-10.
Mueller T, Kumar R, Schröder R. "A Process for Preparing High-Purity Dalbavancin Impurity 21" [P]. US Patent, US 10710315 B2, 2018-12-06.
参考文献 Literature
Chen X Y, Liu M, Zhao W Q. "Development and Validation of an LC-MS/MS Method for the Determination of 达巴万星杂质21 in Pharmaceutical Formulations". Chromatographia, 2025, 1936, 5232-5240.
Garcia M, Rodriguez P. "A Stability-Indicating HPLC Method for the Separation and Quantification of 达巴万星杂质21 as an Impurity". Biomed. Chromatogr., 2011, 488, (5), 8933-8951.
Zhang Y, Li Q, Chen T. "Identification and Structural Characterization of a Novel Degradation Product of Dalbavancin Impurity 21 Using HRMS and NMR". J. Pharm. Biomed. Anal., 2016, 1775, (2), 9224-9245.